Búsqueda | Portal de Búsqueda de la BVS España

1.

Frequent and long-term follow-up of health-related quality of life following allogeneic haematopoietic stem cell transplantation.

Frödin, U; Lotfi, K; Fomichov, V; Juliusson, G; Börjeson, S.

Eur J Cancer Care (Engl); 24(6): 898-910, 2015 Nov.

Artículo en Inglés | MEDLINE | ID: mdl-26156141

2.

A platform for phenotypic discovery of therapeutic antibodies and targets applied on Chronic Lymphocytic Leukemia.

Ljungars, A; Mårtensson, L; Mattsson, J; Kovacek, M; Sundberg, A; Tornberg, U-C; Jansson, B; Persson, N; Emruli, V Kuci; Ek, S; Jerkeman, M; Hansson, M; Juliusson, G; Ohlin, M; Frendéus, B; Teige, I; Mattsson, M.

NPJ Precis Oncol; 2: 18, 2018.

Artículo en Inglés | MEDLINE | ID: mdl-30182064

3.

Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.

Juliusson, G; Billström, R; Gruber, A; Hellström-Lindberg, E; Höglunds, M; Karlsson, K; Stockelberg, D; Wahlin, A; Aström, M; Arnesson, C; Brunell-Abrahamsson, U; Carstensen, J; Fredriksson, E; Holmberg, E; Nordenskjöld, K; Wiklund, F.

Leukemia; 20(1): 42-7, 2006 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-16327841

4.

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Young, E; Noerenberg, D; Mansouri, L; Ljungström, V; Frick, M; Sutton, L-A; Blakemore, S J; Galan-Sousa, J; Plevova, K; Baliakas, P; Rossi, D; Clifford, R; Roos-Weil, D; Navrkalova, V; Dörken, B; Schmitt, C A; Smedby, K E; Juliusson, G; Giacopelli, B; Blachly, J S; Belessi, C; Panagiotidis, P; Chiorazzi, N; Davi, F; Langerak, A W; Oscier, D; Schuh, A; Gaidano, G; Ghia, P; Xu, W; Fan, L; Bernard, O A; Nguyen-Khac, F; Rassenti, L; Li, J; Kipps, T J; Stamatopoulos, K; Pospisilova, S; Zenz, T; Oakes, C C; Strefford, J C; Rosenquist, R; Damm, F.

Leukemia; 31(7): 1547-1554, 2017 07.

Artículo en Inglés | MEDLINE | ID: mdl-27890934

5.

Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.

Juliusson, G; Theorin, N; Karlsson, K; Frödin, U; Malm, C.

Bone Marrow Transplant; 37(5): 503-10, 2006 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-16415894

6.

On the pharmacokinetics of 2-chloro-2'-deoxyadenosine in humans.

Liliemark, J; Juliusson, G.

Cancer Res; 51(20): 5570-2, 1991 Oct 15.

Artículo en Inglés | MEDLINE | ID: mdl-1680554

7.

Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation.

Ostlund, L; Grandér, D; Juliusson, G; Robèrt, K H; Lundgren, E; Einhorn, S.

Cancer Res; 49(12): 3425-30, 1989 Jun 15.

Artículo en Inglés | MEDLINE | ID: mdl-2524252

8.

Cloning of two candidate tumor suppressor genes within a 10 kb region on chromosome 13q14, frequently deleted in chronic lymphocytic leukemia.

Liu, Y; Corcoran, M; Rasool, O; Ivanova, G; Ibbotson, R; Grandér, D; Iyengar, A; Baranova, A; Kashuba, V; Merup, M; Wu, X; Gardiner, A; Mullenbach, R; Poltaraus, A; Hultström, A L; Juliusson, G; Chapman, R; Tiller, M; Cotter, F; Gahrton, G; Yankovsky, N; Zabarovsky, E; Einhorn, S; Oscier, D.

Oncogene; 15(20): 2463-73, 1997 Nov 13.

Artículo en Inglés | MEDLINE | ID: mdl-9395242

9.

High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.

Juliusson, G; Liliemark, J.

J Clin Oncol; 11(4): 679-89, 1993 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-8097528

10.

On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.

Liliemark, J; Albertioni, F; Hassan, M; Juliusson, G.

J Clin Oncol; 10(10): 1514-8, 1992 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-1357107

11.

Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia.

Juliusson, G; Christiansen, I; Hansen, M M; Johnson, S; Kimby, E; Elmhorn-Rosenborg, A; Liliemark, J.

J Clin Oncol; 14(7): 2160-6, 1996 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-8683250

12.

Subcutaneous injections of 2-chlorodeoxyadenosine for symptomatic hairy cell leukemia.

Juliusson, G; Heldal, D; Hippe, E; Hedenus, M; Malm, C; Wallman, K; Stolt, C M; Evensen, S A; Albertioni, F; Tjønnfjord, G.

J Clin Oncol; 13(4): 989-95, 1995 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-7707128

13.

P-Glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with P-glycoprotein-positive acute myeloid leukemia.

Tidefelt, U; Liliemark, J; Gruber, A; Liliemark, E; Sundman-Engberg, B; Juliusson, G; Stenke, L; Elmhorn-Rosenborg, A; Möllgård, L; Lehman, S; Xu, D; Covelli, A; Gustavsson, B; Paul, C.

J Clin Oncol; 18(9): 1837-44, 2000 May.

Artículo en Inglés | MEDLINE | ID: mdl-10784624

14.

Increased frequency of chromosome abnormalities in fibroblasts from hairy cell leukemia patients.

Haglund, U; Stellan, B; Juliusson, G; Gahrton, G.

Leukemia; 11(12): 2105-10, 1997 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-9447827

15.

Molecular analyses of chromosome 12 in chronic lymphocytic leukemia.

Einhorn, S; Burvall, K; Juliusson, G; Gahrton, G; Meeker, T.

Leukemia; 3(12): 871-4, 1989 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-2586180

16.

A FISH cosmid 'cocktail' for detection of 13q deletions in chronic lymphocytic leukaemia--comparison with cytogenetics and Southern hybridization.

Merup, M; Jansson, M; Corcoran, M; Liu, Y; Wu, X; Rasool, O; Stellan, B; Hermansson, M; Juliusson, G; Gahrton, G; Einhorn, S.

Leukemia; 12(5): 705-9, 1998 May.

Artículo en Inglés | MEDLINE | ID: mdl-9593268

17.

Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.

Albertioni, F; Lindemalm, S; Reichelova, V; Pettersson, B; Eriksson, S; Juliusson, G; Liliemark, J.

Clin Cancer Res; 4(3): 653-8, 1998 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-9533533

18.

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Baliakas, P; Hadzidimitriou, A; Sutton, L-A; Rossi, D; Minga, E; Villamor, N; Larrayoz, M; Kminkova, J; Agathangelidis, A; Davis, Z; Tausch, E; Stalika, E; Kantorova, B; Mansouri, L; Scarfò, L; Cortese, D; Navrkalova, V; Rose-Zerilli, M J J; Smedby, K E; Juliusson, G; Anagnostopoulos, A; Makris, A M; Navarro, A; Delgado, J; Oscier, D; Belessi, C; Stilgenbauer, S; Ghia, P; Pospisilova, S; Gaidano, G; Campo, E; Strefford, J C; Stamatopoulos, K; Rosenquist, R.

Leukemia; 29(2): 329-36, 2015 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-24943832

19.

Role of chromosomal abnormalities in chronic lymphocytic leukemia.

Gahrton, G; Juliusson, G; Robèrt, K H; Friberg, K.

Blood Rev; 1(3): 183-92, 1987 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-3332102

20.

Expression of deoxycytidine kinase and phosphorylation of 2-chlorodeoxyadenosine in human normal and tumour cells and tissues.

Spasokoukotskaja, T; Arnér, E S; Brosjö, O; Gunvén, P; Juliusson, G; Liliemark, J; Eriksson, S.

Eur J Cancer; 31A(2): 202-8, 1995.

Artículo en Inglés | MEDLINE | ID: mdl-7718326

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: